41 results
Keyword Trixeo Aerosphere Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Trixeo Aerosphere
formoterol fumarate dihydrate, glycopyrronium bromide, budesonide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 09/12/2020, Revision: 3, Authorised, Last updated: 20/05/2022Trixeo Aerosphere Respiratory Tract Diseases Lung … Trixeo Aerosphere … acknowledged. EMA/561272/2020 EMEA/H/C/004983 Trixeo Aerosphere (formoterol / glycopyrronium … -
List item
Human medicine European public assessment report (EPAR): Riltrava Aerosphere
budesonide, formoterol fumarate dihydrate, glycopyrronium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 06/01/2022, Revision: 1, Authorised, Last updated: 20/05/2022Riltrava Aerosphere Lung Diseases, Obstructive Lung … Riltrava Aerosphere is a medicine used to treat … difficulty breathing. Riltrava Aerosphere is used for maintenance (regular … -
List item
Human medicine European public assessment report (EPAR): Bevespi Aerosphere
glycopyrronium, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 18/12/2018, Revision: 5, Authorised, Last updated: 13/07/2022Bevespi Aerosphere Respiratory Tract Diseases Lung … Bevespi Aerosphere … MEDICINAL PRODUCT Bevespi Aerosphere 7.2 micrograms/5 micrograms … -
List item
National expert: Åsa Kragh, Medical Products Agency (updated)
- Declaration of interests - 80.45 KB | PDF
- Curriculum Vitae - 19.26 KB | PDF
population PK analyses for Trixeo (a.k.a. Breztri Aerosphere submissions. Responsible … responsibility Bevespi Aerosphere COPD Trixeo (Breztri Aerosphere COPD 2.2 Consultancy … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2020
CHMP, Last updated: 16/10/2020Trixeo Aerosphere … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 October 2018
CHMP, Last updated: 19/10/2018Bevespi Aerosphere … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021
CHMP, Last updated: 12/11/2021Riltrava Aerosphere … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022
PRAC, Last updated: 08/07/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 October 2020
Virtual meeting, from 12/10/2020 to 15/10/2020, Last updated: 16/10/202010 3.1.1. Trixeo Aerosphere - budesonide / glycopyrronium … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023
PRAC, Last updated: 13/01/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 09/01/2023 to 12/01/2023, Last updated: 18/08/2021 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/03/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021
PRAC, Last updated: 09/07/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
PRAC, Last updated: 14/01/2022 -
List item
News: Human medicines: highlights of 2020
Last updated: 21/01/2021Kaftrio Palforzia Trepulmix Trixeo Aerosphere Zimbus Breezhaler Haematology/ Haemostaseology Adakveo … -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/05/2021 to 20/05/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 March 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/03/2021 to 25/03/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 8-11 November 2021
Online, from 08/11/2021 to 11/11/2021, Last updated: 20/01/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 November - 1 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 28/11/2022 to 01/12/2022, Last updated: 29/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 13-16 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/12/2021 to 16/12/2021, Last updated: 04/11/2019